Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN63,2563,28-2,59
Msft-3,38
Nokia3,46253,56352,23
IBM-0,85
Mercedes-Benz Group AG65,9265,940,70
PFE1,37
30.05.2024 23:49:47
Indexy online
AD Index online
select
AD Index online
 

  • 30.05.2024 21:59:42
PerkinElmer Inc (PKI, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
108,56 -1,10 -1,21 1 773 222
After-hours30.05.2024 23:08:55
Poslední obchod Nákup / Prodej Změna (%) Změna (USD)
110,44 - - -1,28 -1,41
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 31.05.2024
Popis společnosti
Obecné informace
Název společnostiRevvity Inc
TickerRVTY
Kmenové akcie:Ordinary Shares
RICRVTY.K
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 11 500
Akcie v oběhu k 03.05.2024 123 392 991
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice940 Winter Street
MěstoWALTHAM
PSČ02451
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 816 635 791

Business Summary: Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Revvity Inc revenues decreased 4% to $649.9M. Net income before extraordinary items increased 16% to $28.7M. Revenues reflect Life sciences segment decrease of 8% to $303M, Asia segment decrease of 6% to $177M, Americas segment decrease of 3% to $294.4M, Europe segment decrease of 3% to $178.6M. Net income reflects Corporate segment loss decrease of 23% to $11.4M.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSOther Measuring and Controlling Device Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSTesting Laboratories and Services
NAICSCustom Computer Programming Services
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS2007Other Measuring & Controlling Device Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Testing Laboratories
NAICS2007Custom Computer Programming Services
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Other Measuring and Controlling Device Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Testing Laboratories
NAICS1997Custom Computer Programming Services
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICAnalytical Instruments
SICAnalytical Instruments
SICElectromedical Equipment
SICMeasuring/controlling Devices Nec
SICSurgical And Medical Instruments
SICTesting Laboratories
SICComputer Programming Services
SICCommercial Physical Research



  • Poslední aktualizace: 31.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorPrahlad Singh5930.12.2019
Chief Financial Officer, Senior Vice PresidentMaxwell Krakowiak3406.09.202206.09.2022
Senior Vice President - Administration, General Counsel, SecretaryJoel Goldberg5521.07.200821.07.2008
Senior Vice President - Strategy and Business DevelopmentDaniel Tereau57
Chief Commercial Officer, Senior Vice PresidentMiriame Victor43
Senior Vice President - Global OperationsTajinder Vohra58
Vice President, ControllerAnita Gonzales48